CDK4 and neoplasm: Combination of CDK4/6 inhibition and PD-1 blockade significantly induced tumor cell death in vitro in MC38 murine-derived organoids, as evidenced by tumor live/dead staining as well as by T cell-mediated tumor growth inhibition in vivo in syngeneic MC38 and CT26 mouse models (210).